跳至主要内容
临床试验/ISRCTN31343854
ISRCTN31343854已完成未知

Randomised controlled trial of fibrinolytic aided pleural drainage during chemical pleurodesis for malignant pleural effusion

Department of Health0 个研究点目标入组 40 人开始时间: 2004年9月30日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 40 patients:
  • 1. Confirmed pleural malignancy
  • 2. Recurrent symptomatic pleural effusion
  • 3. Aged 18-85
  • 40 control patients, same criteria.

排除标准

  • Previous pleurodesis

研究者

相似试验

已完成
不适用
Clinical randomization of an Antifibrinolytic agent in Significant HaemorrhageHaemorrhage following trauma
SLCTR/2007/008ondon School of Hygiene and Tropical Medicine
已完成
不适用
Randomized clinical trial for Fibrin Sealant in knee surgerytotal knee replacementknee surgery10005944
NL-OMON31572Sanquin Bloedbank257
进行中(未招募)
1 期
se of fibrinogen in the treatment of bleeding in thrombopenic patients after intensive chemotherapy refractory to platelet transfusio- Major patient- Patient with malignant hemopathy requiring intensive chemotherapy, autologous or allogeneic hematopoietic stem cell transplantation- Grade = 1 hemorrhagic symptom according to WHO - WHO classification- Body weight between 38 and 78 kg- Patient presenting with a platelet refractory state defined according to the Corrected Count Increment (CCI)- Patient affiliated to a social security schemeMedDRA version: 21.1Level: LLTClassification code 10066481Term: Hematological malignancySystem Organ Class: 100000004864
EUCTR2021-000990-10-FRInstitut de Cancérologie Lucien Neuwirth10
进行中(未招募)
不适用
REPLACE (Randomized evaluation of fibrinogen versus placeboin complex cardiovascular surgery): a prospective, multinational,multicenter, randomized, double-blind, placebo-controlled, phaseIII study for the use of Fibrinogen Concentrate (Human) (FCH) incomplex cardiovascular surgeryAcute bleeding while undergoing aortic replacement surgeryMedDRA version: 14.1Level: LLTClassification code 10049052Term: Aortic surgery NOSSystem Organ Class: 100000004865
EUCTR2011-002685-20-PLCSL Behring GmbH152
进行中(未招募)
不适用
REPLACE (Randomized evaluation of fibrinogen versus placeboin complex cardiovascular surgery): a prospective, multinational,multicenter, randomized, double-blind, placebo-controlled, phaseIII study for the use of Fibrinogen Concentrate (Human) (FCH) incomplex cardiovascular surgeryAcute bleeding while undergoing aortic replacement surgeryMedDRA version: 14.1Level: LLTClassification code 10049052Term: Aortic surgery NOSSystem Organ Class: 100000004865
EUCTR2011-002685-20-FICSL Behring GmbH152